
If the future of psychotherapy lies in psychopharmaceuticals and the short-term therapies stipulated by HMOs, argues Yalom, then the profession is in trouble.



Acclaimed author and renowned psychiatrist Irvin D.

If the future of psychotherapy lies in psychopharmaceuticals and the short-term therapies stipulated by HMOs, argues Yalom, then the profession is in trouble.
Acclaimed author and renowned psychiatrist Irvin D.